$353 Million is the total value of venBio Partners LLC's 8 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | RAYZEBIO INC | $114,511,196 | – | 5,158,162 | +100.0% | 32.47% | – | |
| PHVS | PHARVARIS N V | $89,003,705 | +37.8% | 4,264,672 | 0.0% | 25.24% | +8.0% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $46,559,640 | -36.1% | 9,699,925 | 0.0% | 13.20% | -49.9% | |
| Sell | ACELYRIN INC | $39,179,620 | -51.4% | 3,852,470 | -0.1% | 11.11% | -61.9% | |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | $33,929,927 | -6.9% | 1,035,396 | 0.0% | 9.62% | -27.0% | |
| Buy | VENTYX BIOSCIENCES INC | $26,353,124 | +89.5% | 758,800 | +78.9% | 7.47% | +48.5% | |
| ELEV | ELEVATION ONCOLOGY INC | $1,930,985 | -56.4% | 2,914,255 | 0.0% | 0.55% | -65.8% | |
| IMPL | IMPEL PHARMACEUTICALS INC | $1,186,710 | -66.1% | 2,759,791 | 0.0% | 0.34% | -73.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VERONA PHARMA PLC | 15 | Q2 2022 | 22.2% |
| AKERO THERAPEUTICS INC | 14 | Q3 2022 | 65.3% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 73.8% |
| HARMONY BIOSCIENCES HLDGS IN | 13 | Q3 2023 | 21.1% |
| APELLIS PHARMACEUTICALS INC | 11 | Q2 2021 | 62.0% |
| PHARVARIS N V | 11 | Q3 2023 | 25.2% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.3% |
| ELEVATION ONCOLOGY INC | 10 | Q3 2023 | 4.2% |
| VENTYX BIOSCIENCES INC | 8 | Q3 2023 | 42.7% |
| PRECISION BIOSCIENCES INC | 7 | Q3 2020 | 62.0% |
View venBio Partners LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View venBio Partners LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.